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OBJECTIVES The purpose of this study was to demonstrate in patients with moderate to severe heart failure
that exertional dyspnea can be alleviated by improving muscle function.
BACKGROUND Dyspnea is a frequent limiting symptom in patients with chronic heart failure (CHF). This
sensation may originate from activation of receptors in the musculature rather than the lung.
METHODS To investigate whether dyspnea could be alleviated by selective changes in leg muscle
function, we performed isolated lower-limb training in 17 patients with severe CHF. Eight
patients learned guided imagery relaxation techniques and served as an active control group.
Exercise training consisted of three months of low-level bicycle and treadmill exercise such
that minute ventilation was 25 l/min. Leg calisthenics were also performed. Maximal and
submaximal exercise performance, respiratory and quadriceps muscle strength and endurance
and quality-of-life and dyspnea scales were measured before and after each intervention.
Metabolic stress testing (VO2), pulmonary function tests and isokinetic strength testing were
also performed.
RESULTS In the active control group, no changes in leg muscle function, pulmonary function, maximal
and submaximal exercise performance or quality-of-life questionnaires were observed. In the
training group, peak torque of leg flexors (pre: 39  15 ft-lb; post: 50  13 ft-lb; p  0.002)
increased and the fatigue ratio decreased, indicating improved strength and endurance of the
leg muscles. Maximal inspiratory and expiratory mouth pressures and maximum voluntary
ventilation were unchanged. Peak VO2 was increased (pre:12  2.2 ml/kg/min; post: 14 
2.6 ml/kg/min) as well as the duration of exercise at 70% peak VO2 increased (pre: 11.5 
3.1 min; post: 21.5  5.4 min; p  0.003). Perceived dyspnea during the submaximal testing
was decreased. Minnesota Living with Heart Failure Score, Guyatt Dyspnea Scale, and the
Transitional Dyspnea Index were all improved with training (all p  0.05).
CONCLUSIONS We concluded that improvement of limb muscle function alleviates dyspnea and improves
exercise performance in patients with CHF. (J Am Coll Cardiol 2002;40:1602–8) © 2002
by the American College of Cardiology Foundation
Dyspnea is a frequent limiting symptom in patients with
heart failure (HF). The main stimulus for dyspnea in these
patients is unclear and is a subject of intense study. In acute
HF, activation of J receptors in the lung by elevated
pulmonary pressures and/or hypoxia are the primary stimuli
(1). In chronic heart failure (CHF), it has been proposed
that dyspnea originates from the stimulation of metabore-
ceptors in muscles, resulting in increased respiratory drive
through central or peripheral mechanisms (2,3). Marked
metabolic, histochemic and morphologic changes have been
repeatedly demonstrated in the limb musculature of patients
with HF, including a shift from oxidative to glycolytic
metabolism with significant atrophy (4,5). Piepoli et al. (2)
have demonstrated an exaggerated ventilatory response to
stimulation of ergoreceptors that can be ameliorated with
muscle training. Previously we have focused on the respira-
tory muscles and their role in producing dyspnea in patients
with HF. Deoxygenation of the accessory respiratory mus-
cles during exercise (6), increased work of breathing (7),
diminished endurance (8), and decreased strength of the
respiratory muscles (9) have been demonstrated in these
patients. In addition, selective respiratory muscle training
was associated with diminished dyspnea during submaximal
exercise (10). However, it should be noted that these aerobic
exercise-training programs often condition both respiratory
and peripheral muscles, which can diminish the excessive
ventilatory response to exercise (11,12). What is not known
is whether selective training of limb muscles would have the
same effects. The purpose of this study was to investigate
whether dyspnea could be alleviated by selective exercise of
leg muscles at a low level that does not condition the
respiratory muscles. To do this, patients were carefully
trained at a work load that did not increase the minute
ventilation beyond 25 l/min.
METHODS
Patient population. Twenty-nine patients were recruited
and gave their written informed consent to participate in
this study, which was approved by the Human Studies
Committee at Columbia Presbyterian Hospital. A 2:1
randomization was performed for training versus active
control groups. Nine patients were enrolled in an active
control group and 20 patients in the training group. One
patient did not complete the study in the control group and
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three in the training group; therefore, a total of 25 patients
were studied. The baseline clinical characteristics of the
patients are shown in Table 1. Age, gender, etiology of
CHF, oxygen consumption (VO2), and left ventricular
ejection fraction were similar in both groups.
ACTIVE CONTROL GROUP. To overcome the problem of
patient bias, an active control group of patients with CHF
learned guided imagery techniques, the results of which
have been previously published (13). The patients attended
90-min, weekly therapist-guided sessions for 1 month and
were taught a series of relaxation/imagery exercises that
promoted stress reduction. The participants were provided
with a 15-min tape of the images learned during the session
and were instructed to listen to the tapes on an audiocassette
at least twice daily. Patients were encouraged to perform the
mental exercises twice daily.
Exercise training. Supervised training sessions were con-
ducted 3 times/week and consisted of 15 min each of bicycle
and treadmill exercise at a workload corresponding to 50%
of peak VO2 with a minute ventilation 25 l/min and a
heart rate (HR)120 beats/min. A series of leg calisthenics
were performed, including hip flexion and extension with
ankle weights (5 lb/leg) and thigh muscle contraction using
therabands. Each month, an additional set of exercises was
added and ankle weights were increased by 2 lb/leg. The
resistance of the theraband was also increased.
Measurements before and after intervention. A series of
tests were performed before and after each intervention,
including measures of maximal and submaximal exercise
capacity, leg and respiratory muscle strength and endurance,
muscle mass and assessment of dyspnea.
CARDIOPULMONARY TESTING. Maximal bicycle testing was
performed by the patient in the fasting state. Respiratory gas
analysis was measured continuously using a metabolic cart
(Medical Graphics 2001, Minneapolis, Minnesota) via a
disposable pneumotach. After we collected 3 min of rest
data, exercise began at 0 W and increased by 25 W every 3
min until the patient reached exhaustion. Heart rate was
monitored continuously and blood pressure (BP) recorded
with each stage of exercise by cuff sphygmomanometry.
Level of perceived dyspnea and fatigue using the modified
Borg Scale (14) was recorded during each stage of exercise
and at maximum exercise.
Submaximal exercise capacity was evaluated by measuring
the duration of single load of exercise. The selected work-
load corresponded to 70% of peak VO2. Perceived dyspnea
and fatigue was recorded every 5 min using the modified
Borg scale. Oxygen kinetics (O2 kinetics) was determined
using the O2 kinetics software (Medgraphics). The O2
deficit incurred between exercise initiation and the achieve-
ment of steady-state oxygen uptake during submaximal
exercise was determined as previously described (15). It is
calculated as the difference between the oxygen uptake
apparently required and the actual oxygen uptake for the
duration of the low level exercise. The mean response time
(MRT) characterizes the ability of a subject to respond to a
step change in work. MRT is calculated as the inverse of k,
rate constant of the rise in O2 in the dimension of time (16),
expressed in seconds. An unencouraged 6-min walk test was
also performed.
RESPIRATORY AND LEG MUSCLE TESTING. Respiratory
muscle strength was assessed by measuring maximum
mouth pressures. Maximum inspiratory pressure was mea-
sured at residual volume whereas maximum expiratory
pressure was assessed at total lung capacity. Maximum
inspiratory and expiratory pressure were recorded in tripli-
cate or until a stable value was achieved. A 15-s maximum
voluntary ventilation was recorded to assess respiratory
muscle endurance.
Leg muscle strength and endurance were assessed by
isokinetic testing using a dynanonometer (Cybex,
Ronkonkama, New York) as previously described (17). The
resistance of the lever arm is automatically adjusted to the
dynamic tension produced by the muscle throughout its
range of motion and the device records torque during
muscle contraction at a selected angular velocity. In this
study, the dominant leg was tested. The subjects were
positioned in the Cybex at 0° and their upper body move-
ment restricted with a series of straps. The exercise protocol
consisted of five maximal knee extensions and flexions at an
angular velocity of 60° and 120°. The patient then per-
formed 25 rapid contractions at the 120 speed. The fatigue
ratio was defined as the average torque of the last three
repetitions divided by the first three repetitions.
Anthropometric measurements were performed using
Abbreviations and Acronyms
BP  blood pressure
CHF  chronic heart failure
HF  heart failure
HR  heart rate
MRT  mean response time
VO2  oxygen consumption




Age (yrs) 48  4 50  3
Gender (male:female) 6:2 12:5
Height (in) 68  1 68  1
Weight (lb) 170  3 188  6
Etiology (CAD:DCM) 5:3 8:9
LVEF (%) 18  1 20  1
Medications
Furosemide dose (mg/24 h) 197  53 178  23
Digoxin (mg/24 h) 0.20  0.04 0.21  0.01
Beta-blocker 5 of 7 6 of 17
ACE inhibitor 100% 100%
Results are in mean  SEM.
ACE angiotensin-converting enzyme; CAD coronary artery disease; DCM
dilated cardiomyopathy; LVEF  left ventricular ejection fraction.
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Lange calipers (Cambridge Science Instruments, Cam-
bridge, Massachusetts), and a standard tape measure was
used to assess skeletal muscle mass. Skinfold thickness of
the triceps and biceps of the nondominant arm, subscapular,
suprailiac, and midthigh of the nondominant leg were
recorded. Each skinfold measurement was estimated to the
nearest 1 mm and the mean was calculated from three
readings. The circumference of the thigh at one-half and
two-thirds the distance from the iliac crest to the top of the
patella were also recorded.
DYSPNEA TESTING. Dyspnea was assessed using three dif-
ferent quality-of-life questionnaires (18–21). The Minne-
sota Living with Heart Failure Questionnaire queried pa-
tients on all aspects of life with CHF. The score for this
20-question questionnaire ranges from 0 to 100 with a lower
score associated with a better quality-of-life. The Guyatt
Respiratory Scale questionnaire was developed to assess
specific areas of function important to patients with airflow
limitations. A higher score denotes a better quality-of-life.
The Transitional Dyspnea Scale specifically addresses a
change in dyspnea from baseline function. Magnitude of
effort task and function are assessed. A higher score denotes
better functional capacity.
Statistical analysis. Intragroup differences were compared
by paired t testing and intergroup differences by unpaired t
testing. A p value of 0.05 was considered statistically
significant. All results are reported as mean standard error
of the mean.
RESULTS
Cardiopulmonary parameters during maximal and sub-
maximal exercise. Peak VO2 and VO2 at anaerobic thresh-
old was unchanged in the control group. However, signif-
icant increases were observed in training group. The HR
and BP response to exercise was unchanged in both groups.
The ventilatory response to exercise assessed as the ventila-
tory equivalent for carbon dioxide production at 1 l was also
unchanged in both groups (Table 2).
Submaximal exercise performance assessed by the dura-
tion of a single load of exercise was unchanged in the control
group but markedly improved in the training group (Fig. 1).
During submaximal testing, O2 kinetics was only determin-
able in a subgroup of the patients (training, n  5; and
control, n  4). MRT was significantly shorter (p  0.05)
and O2 deficit tended to be less in the training group when
compared with the control group (Table 2). The 6-min walk
test was significantly improved in the training but not in the
control group (Table 2).
Leg and respiratory muscle strength and endurance.
Maximal inspiratory pressure and maximal expiratory pres-
sure were unchanged in both the training or control groups.
Similarly, respiratory muscle endurance assessed by a 15-s
maximum voluntary ventilation was also unchanged in both
groups (Table 3).
Peak flexor and extensor torque at 60° and 120° velocities
at baseline were not significantly different between both
groups. With training, peak flexor and extensor torque
significantly increased in the training but not in the control
group (Table 3). Endurance reflected by the fatigue ratio
was unchanged for both flexors and extensors in the control
group but was significantly improved with training (Table
3). Anthropometric measurements reflecting muscle mass
and fat were unchanged in both groups.
Dyspnea testing. Guided imagery did not significantly
affect the scoring for the Minnesota Living with Heart
Failure or Guyatt Respiratory Scales. Low-level training did
significantly improve both quality-of-life scores (Table 4).
The mean change in the Minnesota Living with Heart
Failure score for the control group was 7 versus 13 in the
low-level training group. The improvement in the transition
score was significantly greater in the low-level training than
the active control group.
Table 2. Maximal and Submaximal Exercise Performance in Control and Training Groups
Control (n  8) Training (n  17)
Pre Post Pre Post
Maximal testing
HR (beats/min)
Rest 81  5 76  6 87  3 82  3
Peak exercise 125  7 127  7 120  4 126  4
MBP (mm Hg)
Rest 90  4 89  4 82  2 81  2
Peak exercise 105  3 102  3 108  3 116  5
VO2AT (ml/kg/min) 9.5  0.9 9.9  0.9 10.2  0.5 11.9  0.5†
Peak VO2 (ml/kg/min) 11.2  0.9 11.6  0.9 12.0  0.5 14.0  0.5†
VE/VCO2 @ 1 l 40  1.4 38  1.2 36  1.2 35  1
Submaximal testing
O2 deficit (ml/min) 683  19 716  67 982  83 676  105
MRT (s) 75.2  6 73.8  16.4 83.5  5 57.4  4*
6-min walk distance (ft) 1,527  121 1,433  163 1,382  60 1,597  65‡
Results are mean  SEM. *p  0.05 Pre vs. Post; †p  0.05 Pre vs. Post; ‡p  0.01.
HR  heart rate; MBP  mean arterial pressure; MRT  mean response time; VE/VCO2 @ 1 l  Ventilation normalized
for 1 l of CO2 production; VO2  oxygen consumption; VO2AT  oxygen consumption at the anaerobic threshold.
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Perceived dyspnea and fatigue during maximal exercise
testing was unchanged in both groups. However, perceived
dyspnea and fatigue were significantly lower during single
load exercise in the training group (Fig. 2).
DISCUSSION
This study had the following main findings. First, low-
intensity lower extremity training significantly improved
lower-extremity strength and endurance and did not alter
respiratory muscle function. Second, this selective exercise-
induced change in lower-leg muscle function improved
submaximal and maximal exercise performance and allevi-
ated dyspnea in these patients with HF. Perceived dyspnea
during a single load of exercise was significantly decreased
with training. Quality-of-life scores were all improved by
training. Thus, our study demonstrates that isolated mod-
ulation of peripheral skeletal muscle function favorably
affects the sensation of dyspnea.
Muscle changes in CHF. Skeletal muscle metabolic, his-
tochemic, and morphologic changes have been described in
patients with CHF (4,5). Similar changes have also been
recently described in patients with severe obstructive lung
Figure 1. Single-load exercise duration in the control and training groups before and after the intervention. The single workload corresponded to 70% peak
oxygen consumption. Filled diamond  pretraining; filled square post-training. *p  0.001 pretraining versus post-training.
Table 3. Leg and Respiratory Muscle Strength, Endurance, and Anthropomorphic
Measurements of Control and Training Groups
Control (n  8) Training (n  17)
Pre Post Pre Post
Leg muscles
Strength (ft-lbs)
Knee flexor torque @ 60° 51  6 53  5 46  3.4 59  3.6*
Knee extensor torque @ 60° 68  4 85  6 64  5.5 84  5
Endurance
Knee extensor fatigue ratio 0.47  0.05 0.52  0.03 0.58  0.03 0.77  0.05*
Knee flexor fatigue ratio 0.52  0.04 0.56  0.05 0.70  0.05 0.92  0.08*
Mass
Thigh circumference
Level 1 53  0.7 53  1.4 54  1 54  1
Level 2 57  1.1 55  1 58  1 56  1
Fat fold (mm)
Level 1 24  3.3 24  2.5 34  3.6 30  3.6
Level 2 25  3.3 25  2.1 32  2.6 33  2.7
Respiratory muscles
Strength (kpscal)
MIP 27  2.8 29  2.8 27  1.7 30  1.9
MEP 35  2.8 32  2.5 33  1.9 36  2.6
Endurance (l)
MVV 90  5.6 83  5.3 93  4.3 90  4.6
Results are mean  SEM. *p  0.05 Pre vs. Post.
Kpscal  kilopascals; Level 1  half the distance from the hip to the top of the patella; Level 2  two-thirds of the distance
from the hip to the top of the patella; MEP  maximal expiratory pressure; MIP  maximal inspiratory pressure; MVV 
maximal voluntary ventilation.
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disease (22,23). These skeletal muscle changes may result
from a combination of deconditioning, malnutrition, in-
flammatory cytokine responses associated with chronic dis-
ease and/or episodic hypoxia to the muscle (4,5). In both
CHF and chronic lung disease, the peripheral muscle may
be the key transducer of the sensation of dyspnea and fatigue
rather than the primary failing organ. Accumulation of
metabolites during exercise in the skeletal muscle may lead
to stimulation of metaboreceptors. Stimulation of intersti-
tial nerve afferents can increase BP, increase vasoconstric-
tion, alter skeletal muscle blood flow, and increase ventila-
tory response (2). Potential chemostimulants include
adenosine, lactate, hydrogen ion, potassium, phosphate, and
hypoxia (2,3). The muscle metaboreceptor has not been well
characterized in patients with HF. Conflicting data exist
whether hyperactivity of these metaboreceptors occur in
patients with HF (2,3).
Mode of training in CHF. Our low-intensity training
protocol selectively improved lower-limb skeletal muscle
strength and endurance without affecting ventilatory and
respiratory muscle function. The absence of any detectable
changes in any of the respiratory muscle strength and
endurance parameters, such as maximal inspiratory pressure,
maximal expiratory pressure, and MVV, supports a lack of a
conditioning effect on respiratory muscles. Low-intensity
training had significant benefits on both submaximal and
maximal exercise performance. This is in agreement with
previous studies that have shown aerobic training at 50% of
peak VO2 to be efficacious in these patients (24–27).
Hambrecht et al. (25) also demonstrated significant histo-
chemic changes in the skeletal muscle with low-intensity
training. The improvement in a single load of endurance,
the shift in the anaerobic threshold and the reduction in O2
deficit observed in this study are consistent with improved
oxidative capacity of the peripheral muscle.
The results of low-level training on sympathetic function
has been variable, with some authors describing a decrease
in resting heart rate and others reporting no change (25–
27). In our study, HR and BP response was not affected
suggesting absence of any autonomic effects.
Previous studies have suggested that low-intensity train-
ing may be beneficial for patients with HF by preventing a
marked increase in myocardial wall stress with left ventricle
overload, leading to further ventricular dilation (27). This
caveat for high-intensity training does not have much
clinical support (28) but in the extremely ill populations,
low-level and/or small muscle mass training may be the only
possible therapeutic approach. In patients with class IV
CHF, a preliminary small muscle mass training program
preceding aerobic training may indeed be beneficial.
The exercise program used in this study combined ele-
ments of isotonic and isometric exercise. The calisthenics
and leg exercises using resistive bands impacted significantly
on the peak muscle strength. The benefit of purely isometric
training in patients with HF is unclear (29), although given
the widespread muscle atrophy of these patients, it should
impact favorably on both function and quality of life.
Effect of selective lower extremity training on dyspnea.
Quality-of-life scores were improved and perception of
dyspnea alleviated by selective leg training, suggesting im-
proved muscle metabolism as the underlying mechanism.
Absence of significant changes in anthropometric measure-
ments before and after training suggest that an increase in
muscle mass did not produce these findings. The ventilatory
response to exercise and respiratory muscle function again
Table 4. Quality-of-Life Scales in the Control and Training
Groups
Control Training
Pre Post Pre Post
Minnesota Living with
Heart Failure Score
41  4.6 33  3.5 50  3.8 37  3*
Guyatt Respiratory
Score
79  5 82  3 74  3 88  5*
Transitional Dyspnea
Scale
— 1.3  0.8 — 3.7  0.5†
Results are mean  SEM. *p  0.05 Pre vs. Post; †p  0.05 Control vs. Training.
Figure 2. Perceived dyspnea using the modified Borg scale during submaximal testing in the training group before and after training. Diamond 
pretraining; square  post-training. *p  0.05, pretraining versus post-training.
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were not affected by this protocol, thus suggesting that local
muscle changes accounted for the alleviation of dyspnea.
Previously, we reported on the benefit of selective respi-
ratory muscle training in alleviation the sensation of dyspnea
in patients with HF (10). How can we reconcile the findings
of these two studies? Both studies support the importance of
muscle function in determining the perception of dyspnea
and fatigue during exercise. Whether both studies illustrate
the effect of learning and the ability to adapt our personal
discomfort threshold is unclear.
Active control group. In this study, the active control
group learned guided imagery techniques. Volitional central
mechanisms can affect respiratory control and thus the
sensation of dyspnea. On a physiologic level, mind-body
techniques can decrease the resting metabolism of the body
(30). Respiratory rate and oxygen consumption during the
meditative state have been shown in some studies to be
reduced (31). The use of yoga in a small group of patients
with HF (32) demonstrated a significant improvement in
exercise performance. Guided imagery is similar to medita-
tion in its use of mental focusing to connect the mind and
body and initiate a relaxation response and regulate respi-
ration. Additionally, the control group had the benefit of
group interaction with specialized attention. Despite this
intervention, the sensation of dyspnea during submaximal or
maximal exercise was unaffected confirming the reproduc-
ibility of the techniques.
Study limitations. This study had several limitations. First,
muscle biopsy data would have provided additional evidence
to support leg muscle training effects. However, the efficacy
of low-level training on muscle using biopsy techniques has
been demonstrated in several studies (26,27). Accordingly,
to increase patient recruitment and compliance, we opted
for a totally noninvasive protocol. The increase in exercise
endurance, muscle strength, and shift in anaerobic threshold
in the trained but not in the control group supports a
training effect. Second, any study focusing on an alteration
in perception is limited by the lack of suitable instruments
that can objectively measure sensations. We attempted to
compensate for this by using multiple dyspnea scales and by
using an active control group. Third, this study is limited in
that it is not able to distinguish between alterations in
metaboreceptors from alterations in the stimuli resulting
from increased active muscle. However, in a recent study by
Scott and colleagues (33), it was shown that the metabore-
ceptor component is probably more important than mech-
anoreceptors in the ventilatory response in patients with
CHF. Lastly, one component of the exercise-training reg-
imen included treadmill exercise and thus global involve-
ment of the skeletal muscle system. However, the low levels
of exercise should limit upper body activity.
Clinical implications. This study provides additional evi-
dence of the importance of the skeletal muscle in generating
the symptoms of CHF. Therapeutic interventions targeted
at altering muscle function such as those that improve
muscle oxidative capacity (34,35), mass (36,37), and/or
substrate utilization (38) may improve the quality of life and
exercise performance in patients with CHF.
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